Received: 22 November 2021
Accepted: 22 July 2022
First Online: 12 September 2022
: Approval was obtained from the Damanhour Oncology Center’s Ethics Committee & Research Ethics Committees of Damanhour University’s Faculty of Pharmacy (Ref. No. 618PP2) in accordance with the Declaration of Helsinki 1975, revised Hong Kong 1989. Prior to participating in the study, all patients signed written informed consent.
: Not applicable.
: The authors declare that they have no competing interests.